Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs low-dose hyaluronidase for vascular complications after hyaluronic acid fillers
IRCT20241113063694N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of hyaluronidase in cardiovascular complications (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
hyaluronidase
03
Conditions
cardiovascular complications
Beyond the preview
Go deeper on IRCT20241113063694N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241113063694N1.